Figure 5.

In vivo fluorescence imaging with orthotopic (breast) tumor bearing mice. The images were obtained two days after the trastuzumab-Cy5.5 or Alexa680 conjugates injection. The target tumor (3T3/HER2+) was specifically imaged with low background with Tra-Alexa680(SQ).